FDA inspection
Nanjing Xingyin Pharmaceutical Group Co. Ltd.: FDA inspection ending Aug 31, 2017
FDA inspection 1024147 · Official Action Indicated (OAI) · Nanjing
Key facts
| Inspection ID | 1024147 |
|---|---|
| Firm | Nanjing Xingyin Pharmaceutical Group Co. Ltd. |
| FEI number | 3011942686 |
| Address | 28 Jichang Road, Lishuixian |
| City | Nanjing |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Aug 31, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data